Hemodialysis in Brazil: differences across geographic regions regarding demographics, laboratory parameters and drug prescription

• Published in: Brazilian Journal of Nephrology Vol. 45; no. 4; pp. 410 - 416
• Main Authors: Nerbass, Fabiana Baggio, Lima, Helbert do Nascimento, Lugon, Jocemir Ronaldo, Sesso, Ricardo
• Format: Journal Article
• Language: English
• Published: Brazil Sociedade Brasileira de Nefrologia 01.01.2023
• Subjects: Adult; Aged; Brazil - epidemiology; Demography; Drug Prescriptions; Epidemiology; Female; Humans; Kidney Failure, Chronic - therapy; Male; Middle Aged; Original; Phosphates; Renal Dialysi; Renal Dialysis; Urea; Brazil
• ISSN: 0101-2800; 2175-8239
• DOI: 10.1590/2175-8239-JBN-2022-0169en

Brazil has a vast territory divided into five geographic regions with important differences in sociodemographic indices. We aimed to present and compare socio-demographic characteristics, biochemical results, and drug prescription of patients on chronic hemodialysis (HD) treatment in the five geographic regions. We evaluated data from the Brazilian Dialysis Registry of all adult patients undergoing chronic HD in 2021. Variables included sociodemographic characteristics, serum levels of phosphate, calcium, and albumin, hemoglobin, urea reduction rate, and prescription of phosphate binders, erythropoietin, and intravenous iron. Data from the North and Northeast regions were combined into one group. A total of 13,792 patients (57.9 ± 16.0 years old, 58.5% male, median HD vintage of 31 (11-66) months) from 73 dialysis centers were analyzed. Regional distribution was 59.5% in the Southeast; 21.7% in the South; 5.9% in the Midwest; and 12.9% in the North/Northeast. Sociodemographic features, biochemical results, and medication prescriptions differed across regions. The prevalence of elderly patients was lower in the Midwest and North/Northeast. The South region had the highest prevalence of hyperphosphatemia (41.2%) and urea reduction rate <65% (24.8%), while anemia and hypoalbuminemia were more prevalent in the Southeast, 32.7% and 11.6%, respectively. We found differences in socio-demographics, clinical features, and drug prescriptions across Brazilian geographic regions. Some findings reflect the socio-demographic diversity of the country, while others deserve further elucidation.